Company profile
VITASPRING BIOMEDICAL CO. LTD. CIK 1697884
Ticker
VSBC (OTC)
Industry
Services-Commercial Physical & Biological Research
Headquarters
Riverside, CA 92507
Fiscal year end
2026 (FY)
Key Financials
Revenue
$0
Net income
-$415.4K
Total assets
$14.7K
Total liabilities
$4.45M
Stockholders' equity
-$4.43M
Cash & equivalents
$2.1K
Operating income
-$385.4K
Operating cash flow
-$2.7K
Capital expenditures
—
Fiscal year 2026, via 10-K filed 2026-06-17. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
30,289.2%
Equity / assets
-30,189.2%
CapEx / revenue
—
Operating cash flow / net income
0.01×
Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026
$0
-$415.4K
$14.7K
$4.45M
-$4.43M
2025
$0
-$774.9K
$14.4K
$4.03M
-$4.02M
2024
$0
-$1.12M
$137.3K
$3.49M
-$3.35M
2023
$0
-$4.16M
$765.9K
$3.16M
-$2.40M
2022
$5.61M
$909.6K
$3.60M
$2.03M
$1.58M
Company Details
SIC code
8731
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-09-17
Financials filed via
Form 10-K
filed 2026-06-17
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Riverside, CA 92507
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.